RhumbLine Advisers’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $50.8K | Sell |
|
|||||
|
2024
Q4 | $73K | Hold |
|
|||||
|
2024
Q3 | $92.8K | Sell |
|
|||||
|
2024
Q2 | $142K | Buy |
|
|||||
|
2024
Q1 | $391K | Buy |
|
|||||
|
2023
Q4 | $1.06M | Buy |
|
|||||
|
2023
Q3 | $707K | Sell |
|
|||||
|
2023
Q2 | $815K | Buy |
|
|||||
|
2023
Q1 | $766K | Buy |
|
|||||
|
2022
Q4 | $702K | Buy |
|
|||||
|
2022
Q3 | $835K | Buy |
|
|||||
|
2022
Q2 | $585K | Buy |
|
|||||
|
2022
Q1 | $483K | Buy |
|
|||||
|
2021
Q4 | $682K | Buy |
|
|||||
|
2021
Q3 | $525K | Buy |
|
|||||
|
2021
Q2 | $502K | Buy |
|
|||||
|
2021
Q1 | $230K | Sell |
|
|||||
|
2020
Q4 | $221K | Buy |
|
|||||
|
2020
Q3 | $321K | Sell |
|
|||||
|
2020
Q2 | $345K | Buy |
|